The following variables were associated with an elevated cTnT level: male gender (OR 2.61 (1.46, 4.70), p = 0.001), diabetes (OR 4.66 (2.49, 9.10), p<0.0001), dialysis (OR 3.57 (1.99, 6.53), p<0.0001), prior history of CVE (OR 4.61 (2.38, 9.37), p<0.0001), presence of LVH (OR 5.31 (2.24, 14.8), p<0.0001), positive cardiac stress test (OR 5.82 (1.89, 25.5), p = 0.006) and hyperphosphatemia (OR 4.71 (1.50, 16.1), p = 0.01). This evidence concerns the gene TNNT2 and hyperphosphatemia.